Connect with us


Rehametrics: Quantifying Physical and Cognitive Rehabilitation During the COVID-19 Pandemic

kokou adzo



Pablo Gagliardo Rehametrics

We talked to Pablo Gagliardo of Rehametrics about the only virtual rehabilitation software platform specifically designed to jointly rehabilitate physical and cognitive aspects in any healthcare setting, and he had the following to say:-

First of all, how are you and your family doing in these COVID-19 times?

Pablo Gagliardo: Well, we’re all doing fine. We’ve been very lucky not to be directly affected by COVID-19 so far. And I really hope that things remain that way. I also hope that everyone at and its readers remain healthy over the coming months.

Tell us about you, your career, how you founded Rehametrics.

Pablo Gagliardo: Although I am currently in the healthcare industry, I am an engineer by training. However, since I graduated from university, I have held positions in R&D, product management and marketing in the telecommunications, semiconductor and healthcare industries. Working in different industries and in various positions within those industries has been very helpful to obtain a “broader view” of the market, which eventually enabled me to start Rehametrics a few years ago.

As a result, the way the company started is actually linked to my background. Several years ago, I started working for a private healthcare group in Valencia, Spain, where one of my main objectives was to apply technology to solve the everyday issues faced by patients and healthcare professionals. In this case, my engineering background was very useful and, eventually, enabled me to find a “problem” that was challenging enough to require starting a company to provide a solution for it. That is how Rehametrics was born.

How does Rehametrics innovate?

Pablo Gagliardo: Well, because of the nature of our product and business model, we have to be constantly innovating. Our business model is subscription-based, so we have to constantly improve our product to ensure that our customers are satisfied. Otherwise, they simply would not use our software and thus, would not need to renew their subscriptions. This forces us to be continually innovating, so it is in our DNA. I really believe this is a win-win situation for everyone: our customers get a better product and continuously improve our solution, attracting more customers.

How the coronavirus pandemic affects your business, and how are you coping?

Pablo Gagliardo: The coronavirus pandemic has mainly affected our business in two ways. First of all, it forced everyone at Rehametrics to have to work from home. We had previously worked from home for one or two days at a time, but never something like this. COVID-19 forced everyone in the company to work from home for a prolonged period. We started back in February, and we are still going strong! And this is very likely to continue for several more months. The interesting thing is that, contrary to expectations, we are able to work very efficiently even though we have not seen each other face-to-face in months!

On the other hand, from a commercial perspective, our customer preferences have also changed. Although Rehametrics has products that can be used to deliver physical and cognitive rehabilitation both in clinical and home settings, our product mix was 70% clinical and 30% home before the pandemic. This reflected the fact that normally, healthcare organizations were more conservative and initially used Rehametrics within clinical settings before using it in the patient’s home.

However, our product mix has changed during the pandemic: it is now closer to 40% clinical and 60% home. This, of course, is because a lot of patients prefer to do their rehabilitation at home, nowadays. In our case, the fact that Rehametrics was prepared to offer those services to our customers allowed us to provide a solution to them when it was most needed.

Did you have to make difficult choices, and what are the lessons learned?

Pablo Gagliardo: I think one of the most difficult choices we had to make during this year was to change our product roadmap to be a bit more short-term, prioritizing features that could be more useful to our customers during the pandemic. We had to move fast, and we were able to do so. One of the things we definitely learned during this year was how to improve our decision-making process.

How do you deal with stress and anxiety? How do you project yourself and Rehametrics in the future?

Pablo Gagliardo: Stress? Anxiety? What is that? LOL. Now seriously, in my case, I try to spend quality time with my family and friends. As you can imagine, this has been a bit more difficult this year. Also, whenever possible, I also like to go running. I try to go at least three times a week. And I also enjoy reading in particular books on physics, astrophysics and history.

On the other hand, speaking about the future nowadays can be tricky. I think it is important to have goals but also to be flexible.

Who are your competitors? And how do you plan to stay in the game?

Pablo Gagliardo: Although virtual rehabilitation is a relatively new market segment, several companies offer products to healthcare organizations. However, Rehametrics is the only company offering a fully-integrated solution for both physical, cognitive and language rehabilitation that can be used in both clinical and home settings.

As I mentioned before, innovation is part of our DNA: we are continually thinking of ways to improve our products, add new features, exercises, clinical reports, etc. On average, we normally have 2-3 product updates every year, where we add improvements already in our product roadmap or those requested by our customers and partners. This means that we are constantly improving our solution, which means constant innovation and listening to our customers. Of course, this is one of the main competitive advantages that has enabled us to deliver a best-in-class solution: none of our competitors has a product as complete, innovative, and with as extensive quantification capabilities as the product offered Rehametrics.

Your final thoughts?

Pablo Gagliardo: Like everything else in our lives, the current pandemic will pass and yes, things will go back to normal. Let’s try to find opportunities to help society with our innovations during the current pandemic and beyond. But, above all, stay healthy!

Your website?

Kokou Adzo is the editor and author of He is passionate about business and tech, and brings you the latest Startup news and information. He graduated from university of Siena (Italy) and Rennes (France) in Communications and Political Science with a Master's Degree. He manages the editorial operations at

1 Comment

1 Comment

  1. Nancy Smith

    04/05/2021 at 11:13 AM

    The rehabilitation facility must be considered to be a primary factor in the determination of the appropriate treatment. They chosen facility must have facilities and utilities in order to suit the needs of the patient. This important factor must be considered very carefully since it is usually related to the success or failure of the rehabilitation endeavor.
    The actual treatments should also be determined in relation to the drug use of the patient. They need to be aware of the kind of drug that caused the addiction, its dosage, frequency of drug use as well as its duration.

Leave a Reply

Your email address will not be published. Required fields are marked *

Top of the month

Copyright © 2023 STARTUP INFO - Privacy Policy - Terms and Conditions - Sitemap - Advisor


We are a global Innovative startup's magazine & competitions host. 12,000+ startups from 58 countries already took part in our competitions. STARTUP.INFO is the first collaborative magazine (write for us or submit a guest post) dedicated to the promotion of startups with more than 400 000+ unique visitors per month. Our objective : Make startup companies known to the global business ecosystem, journalists, investors and early adopters. Thousands of startups already were funded after pitching on

Get in touch : Email : contact(a) - Phone: +33 7 69 49 25 08 - Address : 2 rue de la bourse 75002 Paris, France